Enhancing the anti-lymphoma potential of 3,4-methylenedioxymethamphetamine ('ecstasy') through iterative chemical redesign: mechanisms and pathways to cell death.
about
Enhancing the anti-lymphoma potential of 3,4-methylenedioxymethamphetamine ('ecstasy') through iterative chemical redesign: mechanisms and pathways to cell death.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Enhancing the anti-lymphoma po ...... ms and pathways to cell death.
@ast
Enhancing the anti-lymphoma po ...... ms and pathways to cell death.
@en
Enhancing the anti-lymphoma po ...... ms and pathways to cell death.
@nl
type
label
Enhancing the anti-lymphoma po ...... ms and pathways to cell death.
@ast
Enhancing the anti-lymphoma po ...... ms and pathways to cell death.
@en
Enhancing the anti-lymphoma po ...... ms and pathways to cell death.
@nl
prefLabel
Enhancing the anti-lymphoma po ...... ms and pathways to cell death.
@ast
Enhancing the anti-lymphoma po ...... ms and pathways to cell death.
@en
Enhancing the anti-lymphoma po ...... ms and pathways to cell death.
@nl
P2093
P2860
P1476
Enhancing the anti-lymphoma po ...... ms and pathways to cell death.
@en
P2093
Agata M Wasik
Anita Challa
Anita Chamba
Dagmar Scheel-Toellner
John Gordon
Katie D Lewis
Martin J Dyer
Matthew J Piggott
Matthew McIldowie
Michael N Gandy
P2860
P2888
P304
P356
10.1007/S10637-011-9730-5
P577
2011-08-18T00:00:00Z
P6179
1044087141